Sugi Predict

Sugi Predict / Compounds / SCHEMBL21045699

SCHEMBL21045699

SCHEMBL21045699

COc1cc(N)ncc1C1=CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM1 Q13255 8/20 0.50
▸ GRM5 P41594 7/20 0.50
▸ PDK4 Q16654 1/20 0.49
▸ BTK Q06187 1/20 0.49
▸ CYP11B2 P19099 1/20 0.47
▸ JAK1 P23458 1/20 0.45
▸ TNK2 Q07912 1/20 0.44
▸ FGFR1 P11362 1/20 0.44
▸ EED O75530 2/20 0.44
▸ RBBP4 Q09028 2/20 0.44
▸ SUZ12 Q15022 2/20 0.44
▸ EZH2 Q15910 2/20 0.44
▸ HTR6 P50406 1/20 0.43
▸ GABRP O00591 1/20 0.43
▸ GABRD O14764 1/20 0.43
▸ GABRA1 P14867 1/20 0.43
▸ GABRB1 P18505 1/20 0.43
▸ GABRG2 P18507 1/20 0.43
▸ GABRB3 P28472 1/20 0.43
▸ GABRA5 P31644 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30439968 1.00 GRM1 (0.50) GRM1GRM5PDK4BTKCYP11B2
SCHEMBL21045851 0.89 JAK1 (0.49) GRM1GRM5PDK4BTKCYP11B2
SCHEMBL29774097 0.89 JAK1 (0.49) GRM1GRM5PDK4BTKCYP11B2
SCHEMBL1804728 0.87 PDK4 (0.51) GRM1GRM5PDK4BTKCYP11B2
SCHEMBL30439316 0.87 PDK4 (0.51) GRM1GRM5PDK4BTKCYP11B2
SCHEMBL21245699 0.86 PDK4 (0.50) GRM1GRM5PDK4BTKCYP11B2
SCHEMBL30198515 0.86 PDK4 (0.50) GRM1GRM5PDK4BTKCYP11B2
SCHEMBL21045954 0.85 QDPR (0.42) —
SCHEMBL23047394 0.85 GRM1 (0.48) GRM1GRM5PDK4BTKCYP11B2
SCHEMBL31168629 0.85 CYP11B2 (0.45) GRM1GRM5PDK4BTKCYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752499-B1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INT (DE) 2024-03-27 — — EP disclosed
US-RE49699-E1 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-10-17 — — US disclosed
US-RE49699-E1 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-10-17 — — US disclosed
US-RE49699-E1 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-10-17 — — US disclosed
CN-111527078-B Pyridinecarbonyl derivatives and their therapeutic use as TRPC6 inhibitors 勃林格殷格翰国际公司 2023-06-02 — — CN disclosed
EP-3700902-B1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INT (DE) 2023-03-08 — — EP disclosed
US-11485740-B2 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-11-01 — — US disclosed
EP-3786160-B1 PYRIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF AS TRPC6 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2022-07-13 — — EP disclosed
EP-3786160-B1 PYRIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF AS TRPC6 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2022-07-13 — — EP disclosed
US-11370771-B2 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-06-28 — — US disclosed
US-20200399282-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2020-12-24 — — US disclosed
US-10800757-B2 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2020-10-13 — — US disclosed
US-10800757-B2 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2020-10-13 — — US disclosed
CN-111527078-A Pyridinecarbonyl derivatives and their therapeutic use as TRPC6 inhibitors 勃林格殷格翰国际公司 2020-08-11 — — CN disclosed
WO-2019161010-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-08-22 — — WO disclosed
WO-2019158572-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-08-22 — — WO disclosed
US-20190169168-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-06-06 — — US disclosed
US-20190169167-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2019-06-06 — — US disclosed
US-20190169167-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2019-06-06 — — US disclosed
US-20190169168-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-06-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200399282-A1 INHIBITORS OF TRPC6 TRPC6, TRPC1, TRPC4 GRM1 3400/4885GRM5 3555/4885PDK4 1831/4885
US-20190169168-A1 INHIBITORS OF TRPC6 TRPC6, TRPC1, TRPC7 GRM1 3862/4885GRM5 3585/4885PDK4 2256/4885
US-11485740-B2 Inhibitors of TRPC6 TRPC6, TRPC1, TRPC4 GRM1 3400/4885GRM5 3555/4885PDK4 1831/4885
US-20190169167-A1 INHIBITORS OF TRPC6 TRPC6, TRPC1, TRPC7 GRM1 3862/4885GRM5 3585/4885PDK4 2256/4885
US-10800757-B2 Inhibitors of TRPC6 TRPC6, TRPC1, TRPC7 GRM1 3862/4885GRM5 3585/4885PDK4 2256/4885
US-11370771-B2 Inhibitors of TRPC6 TRPC6, TRPC1, TRPC4 GRM1 3439/4885GRM5 3053/4885PDK4 1906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.